Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 565-576 of 8671

PR Newswire associated0

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

PR Newswire associated0

Abacus Unveils Unified Brand Following 2025 Merger with Medicus IT

ACCESS Newswire logo

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Business Wire logo

Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Binders

PR Newswire associated0

JD.com Announces European Brand Partnerships at Alimentaria Barcelona

Business Wire logo

Latent-Y: The Autonomous AI Agent for Drug Design at Scale

New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress

Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial

PR Newswire associated0

Coreline Soft Supplies Lung Cancer Screening AI to Charité - Universitätsmedizin Berlin

ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update

PR Newswire associated0

Monash University and ClinChoice Forge Strategic Partnership to Accelerate Clinical Development of Innovative Therapies

Business Wire logo

Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing

  • Prev Page
  • 1
  • 2
  • …
  • 47
  • 48
  • 49
  • …
  • 722
  • 723
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us